Enjoy complimentary customisation on priority with our Enterprise License!
The high performance biomaterials market size is forecast to increase by USD 8.48 billion, at a CAGR of 11.29% between 2023 and 2028. The high performance biomaterials market is experiencing significant growth due to several key factors. The rising prevalence of musculoskeletal diseases and disorders, dental diseases and restoration and related risk factors is driving demand for advanced biomaterials in medical applications. Additionally, the increasing number of joint replacement and arthroplasty surgeries necessitates the use of high performance biomaterials for implants and other surgical devices. These trends are expected to continue, fueling market expansion in the healthcare sector. Furthermore, technological advancements in biomaterial science and engineering are leading to the development of innovative materials with superior properties, enhancing their utility and demand. It also includes an in-depth analysis of drivers, trends, and challenges.
The market report predicts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018-2028.
The market share growth by the metallic segment will be significant during the forecast years. Metallic materials are considered critical bio-engineering materials, as they are used because of their excellent thermal conductivity and mechanical properties. Metallic high-performance biomaterials have been used extensively in biomedical devices and components, like replacements for hard tissue, cardiac and cardiovascular stents, and others, due to their suitable mechanical properties and biocompatibility.
Get a glance at the market contribution of the End User segment Request Free Sample
The metallic segment accounted for USD 3.49 billion in 2018. Moreover, metallic products are strong as well as resistant to deterioration due to fatigue. Thus, they are widely used in orthopedic surgical procedures, such as joint replacements, orthopedic fixations, and aortic stent. Furthermore, metallic products are used in dental surgeries. Therefore, the wide applications of metallic high-performance biomaterials will drive the growth of the segment of the market during the forecast period.
The orthopedics?segment will account for the largest share of this segment.The orthopedics aid in joint replacements, bone grafting, and tissue repair. Demand rises with increasing diagnoses of bone disorders and joint-related issues, particularly among the elderly. Technological advancements, including 3D printing and biodegradable materials, further fuel market growth for orthopedic biomaterials during the forecast period.
North America is estimated to contribute 38% to the growth of the global market during the projection period.
Technavio's analysts have provided extensive insight into the market forecasting, detailing the regional trends and drivers influencing the market's trajectory throughout the projection period.
For more insights on the market share of various regions Request Free Sample
In 2023, the US and Canada dominated North America's market due to factors like prevalent orthopedic disorders, advanced medical device adoption, and strong vendor presence. RevBio secured a USD 3.4 million NIH grant to advance late-stage product development and conduct clinical trials on its TETRANITE technology for bone growth stimulation. Rising orthopedic conditions and an aging population are driving the demand. Government initiatives, healthcare spending, and favorable regulations further propel market growth, especially in regenerative medicine. The US boasts a supportive regulatory environment for such innovations, facilitating product approvals and market expansion. Hence, such factors will have a positive impact on the regional market during the forecast period.
Its derived from synthetic, natural, and other sources and are meant to restore or replace the functions of human organs or tissues. These materials have high biocompatibility and strength, owing to which they are used in medical devices, orthopedic implants, and tissue engineering scaffolds, among other healthcare applications.
To Know more about the market report Request Free Sample
Our researchers analyzed the market research and growth data with 2023 as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage.
The rising prevalence of dental diseases and related risk factors, including musculoskeletal and chronic skeletal medical conditions, drives the biomaterials market. The surge in dental diseases such as periodontal diseases, dental caries, and oral cancer is alarming globally. Despite efforts to mitigate dental caries, its prevalence continues to rise, affecting a significant portion of the population, particularly geriatric individuals. Furthermore, the escalating prevalence of osteoporosis and osteoarthritis exacerbates dental health challenges, especially among the elderly. Factors like diabetes like Type 2 diabetes, poor oral hygiene, stress, and tobacco and alcohol consumption contribute to the increasing incidence of dental diseases.
Moreover, the growing prevalence of complete tooth loss among older demographics amplifies the demand for biomaterial-based implants and orthopedic implants. These materials cater to the need for prostheses, thus driving market expansion during the forecast period. As dental diseases continue to pose significant health concerns, the market for biomaterials is poised for substantial growth to meet the rising demand for innovative solutions.
Progressive research on regenerative medicine is the primary trend shaping the market. It has function as scaffolds in regenerative medicine, facilitating the proliferation of human cells, encouraging biological signals, offering structural support, and mobilizing endogenous cells needed for tissue repair. Regenerative medicine involves the use and other technologies to repair or replace damaged tissues and organs or to stimulate the body's natural healing process.
Additionally, this product plays a crucial role in regenerative medicine by delivering a scaffold or framework for the growth of new tissue by promoting cell attachment and proliferation and controlling cell behavior. Furthermore, market players offer for regenerative medicine. Thus, the market trends is expected to continue growing during the forecast period, driven by the increasing focus on regenerative medicine.
Issues related to the safety and mechanical strength is a challenge that affects the market. Even when it show safety in the laboratory environment, problems with material corrosion and infection of surrounding tissues need to be taken into care when using the implant in vivo for an extended length of time. A significant problem, especially with metallic biomaterials, is corrosion. Other concerns include cellular toxicity and allergy responses triggered by the material's ion elution.
Consequently, biocompatibility has to be taken into account while developing new products using this material, which need to be chosen carefully based on their intended use. Furthermore, as surface modification is often necessary to promote their interaction with living tissues, the mechanical strength of the biomaterials used in the implant or device may decrease, which may impede market growth during the forecast period.
Companies are implementing various market growth and forecasting strategies by analyzing factors such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product or service launches, to enhance their presence in the market.
The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Arctic Biomaterials Oy Ltd, BASF SE, Berkeley Advanced Biomaterials, CAM Bioceramics BV, CoorsTek Inc., Corbion nv, Covestro AG, Dentsply Sirona Inc., Evonik Industries AG, Himed LLC, Honeywell International Inc., Koninklijke DSM NV, Regenity Biosciences, RevBio Inc., Solesis, Stryker Corp., Victrex Plc, Zimmer Biomet Holdings Inc., and ZimVie Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is witnessing significant growth, driven by increasing prevalence of musculoskeletal and chronic skeletal medical conditions such as osteoarthritis and osteoporosis, especially among the geriatric population. Biomaterial-based implants, particularly in orthopedic applications, are revolutionizing treatments. Advanced technologies like polymerase chain reaction (PCR) and non-PCR methods are enhancing diagnosis and therapeutics. Smart biomaterials are enabling controlled drug delivery, while engineered tissues and cell-cultured models are aiding in tissue regeneration. Porous-coated orthopedic implants, often made using powder metallurgy or additive manufacturing, offer superior properties like adjustable elastic modulus and enhanced biocompatibility. The market is also driven by growth in plastic surgery procedures and the development of bioelectric signal-based biosensors and analytical devices. These technological advancements in biomaterials are poised to reshape the healthcare landscape, offering innovative solutions for a range of medical needs.
In the realm of healthcare, are catalysts for innovation, addressing a spectrum of challenges from musculoskeletal disorders to drug deliveries and Vaccines administration. These materials serve as therapeutic tools within biological systems, facilitating novel drug delivery approaches and enabling controlled release of drugs through porous structures and bioelectric signals. Product insights reveal a diverse landscape, with the polymer product segment leading the forefront, encompassing biopolymers, advanced polymers, and bio-resorbable tissue fixation solutions. Both Natural biomaterials and synthetic biomaterials find application, emphasizing biodegradability and remodeling capabilities crucial for orthopedic and plastic surgery segments.
Orthopedic applications benefit from materials like poly-ether-ether-ketone (PEEK) and titanium, ensuring durability and compatibility with native tissues. In the plastic surgery segment, biomaterials play a pivotal role in cosmetic procedures, offering versatile solutions for aesthetic enhancements. Piezoelectric scaffolds represent a promising frontier, harnessing bioelectric signals for tissue regeneration and repair. The market's trajectory underscores the significance of innovative biomaterials in shaping the future of healthcare, offering tailored solutions to diverse clinical needs while advancing patient outcomes and quality of life.
Market Scope |
|
Report Coverage |
Details |
Page number |
183 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 11.29% |
Market Growth 2024-2028 |
USD 8.48 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
10.21 |
Regional analysis |
North America, Europe, APAC, South America, and Middle East and Africa |
Performing market contribution |
North America at 38% |
Key countries |
US, China, Japan, Germany, and UK |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Advanced Medical Solutions Group Plc, Arctic Biomaterials Oy Ltd, BASF SE, Berkeley Advanced Biomaterials, CAM Bioceramics BV, CoorsTek Inc., Corbion nv, Covestro AG, Dentsply Sirona Inc., Evonik Industries AG, Himed LLC, Honeywell International Inc., Koninklijke DSM NV, Regenity Biosciences, RevBio Inc., Solesis, Stryker Corp., Victrex Plc, Zimmer Biomet Holdings Inc., and ZimVie Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.